Barclays PLC increased its position in shares of Herbalife Ltd. (NYSE:HLF - Free Report) by 347.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 161,426 shares of the company's stock after buying an additional 125,311 shares during the period. Barclays PLC owned about 0.16% of Herbalife worth $1,160,000 at the end of the most recent reporting period.
Several other hedge funds also recently added to or reduced their stakes in HLF. Baupost Group LLC MA lifted its holdings in shares of Herbalife by 128.3% during the second quarter. Baupost Group LLC MA now owns 5,124,526 shares of the company's stock worth $53,244,000 after purchasing an additional 2,879,603 shares during the period. Marshall Wace LLP lifted its stake in shares of Herbalife by 2,053.6% in the 2nd quarter. Marshall Wace LLP now owns 1,977,155 shares of the company's stock valued at $20,543,000 after purchasing an additional 1,885,346 shares in the last quarter. Renaissance Technologies LLC lifted its stake in shares of Herbalife by 11.6% in the 2nd quarter. Renaissance Technologies LLC now owns 6,653,401 shares of the company's stock valued at $69,129,000 after purchasing an additional 692,800 shares in the last quarter. Iridian Asset Management LLC CT lifted its stake in shares of Herbalife by 43.7% in the 3rd quarter. Iridian Asset Management LLC CT now owns 2,228,193 shares of the company's stock valued at $16,021,000 after purchasing an additional 677,739 shares in the last quarter. Finally, Bank of Montreal Can lifted its position in Herbalife by 15.3% during the 2nd quarter. Bank of Montreal Can now owns 3,776,641 shares of the company's stock worth $41,354,000 after acquiring an additional 500,876 shares in the last quarter.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on the company. StockNews.com raised Herbalife from a "hold" rating to a "buy" rating in a research report on Monday, November 4th. B. Riley dropped their price objective on Herbalife from $17.00 to $12.00 and set a "buy" rating on the stock in a report on Thursday, October 31st. Citigroup dropped their price objective on Herbalife from $16.00 to $13.00 and set a "buy" rating on the stock in a report on Friday, October 25th. DA Davidson dropped their price objective on Herbalife from $13.00 to $7.50 and set a "neutral" rating on the stock in a report on Thursday, October 31st. Finally, Mizuho lifted their price objective on Herbalife from $8.00 to $9.00 and gave the stock a "neutral" rating in a report on Friday, November 1st. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, Herbalife presently has a consensus rating of "Hold" and a consensus target price of $9.90.
Read Our Latest Stock Report on HLF
Herbalife Price Performance
Shares of Herbalife stock traded down $0.35 during trading on Tuesday, hitting $6.11. The stock had a trading volume of 1,330,347 shares, compared to its average volume of 1,725,070. The firm has a market cap of $615.84 million, a P/E ratio of 7.19, a PEG ratio of 0.26 and a beta of 1.18. The business has a fifty day moving average of $7.48 and a two-hundred day moving average of $8.23. Herbalife Ltd. has a fifty-two week low of $6.05 and a fifty-two week high of $13.30.
Herbalife (NYSE:HLF - Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.57 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.19 by $0.38. The company had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.23 billion. Herbalife had a negative return on equity of 18.66% and a net margin of 1.73%. As a group, research analysts forecast that Herbalife Ltd. will post 1.51 earnings per share for the current year.
Herbalife Profile
(
Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Featured Articles
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.